Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

ʻO ka maʻi Leukemia Lymphoblastic ʻoʻoleʻa (T-ALL)-05

MaʻiʻAʻohe inoa

Kāne/WahineKāne

Makahiki15 makahiki

Lāhui: Pākē

ʻIkepiliʻO ka maʻi leukemia lymphoblastic koʻikoʻi (T-ALL)

    Hoʻomaha ʻia o kahi maʻi T-ALL i hoʻi hou me ka Leukemia ʻōnaehana nerve waena ma hope o ka lāʻau CAR-T


    Pili kēia hihia i kahi keikikāne 16 makahiki mai ka Hikina ʻĀkau o Kina, nona ka huakaʻi me ka leukemia i piha i nā pilikia mai kona wā i ʻike ʻia ai he maʻi ia ma mua o hoʻokahi makahiki i hala.


    Ma Nowemapa 8, 2020, ua kipa aku ʻo Dawei (he inoa kapakapa) i kahi haukapila kūloko ma muli o ka ʻoʻoleʻa o ka maka, ka ʻulaʻula, a me ka waha kekee. Ua ʻike ʻia ʻo ia me ka "acute lymphoblastic leukemia (ʻano T-cell)." Ma hope o hoʻokahi papa hana chemotherapy induction, ua maikaʻi ʻole ka MRD (minimal residual disease), a ukali ʻia e ka chemotherapy maʻamau. I loko o kēia wā, ʻaʻohe ʻano ʻē i hōʻike ʻia e ka puncture bone marrow, lumbar puncture, a me nā injections intrathecal.


    Ma Mei 6, 2021, ua hana ʻia kahi puncture lumbar me ka injection intrathecal, a ua hōʻoia ka loiloi wai cerebrospinal (CSF) i ka "leukemia ʻōnaehana nerve waena." Ua ukali ʻia kēia e ʻelua mau papa o ka chemotherapy maʻamau. Ma Iune 1, ua hōʻike kahi puncture lumbar me ka loiloi CSF i nā cell immature. Ua lawelawe ʻia ʻekolu mau puncture lumbar hou me nā injections intrathecal, me ka hoʻāʻo CSF ​​hope loa e hōʻike ana ʻaʻohe cell tumor.


    Ma Iulai 7, ua nalowale ka ʻike o Dawei ma kona maka ʻākau, a ua emi iho i ka ʻike ʻana i ka mālamalama wale nō. Ma hope o hoʻokahi papa hana chemotherapy ikaika, ua hoʻi hou ka ʻike o kona maka ʻākau i ka maʻamau.


    Ma ʻAukake 5, ua hōʻino hou ka ʻike o kona maka ʻākau, a ua lilo i makapō loa, a ua lilo kona maka hema i mea pohihihi. Mai ʻAukake 10 a 13, ua hana ʻia ʻo ia i ka radiotherapy lolo holoʻokoʻa a me ke kaula spinal (TBI), ka mea i hoʻihoʻi i ka ʻike ma kona maka hema, akā ua noho makapō ka maka ʻākau. Ma ʻAukake 16, ua hōʻike kahi scan MRI o ka lolo i kahi hoʻomaikaʻi iki i ka mānoanoa o ke aʻalolo optic ʻākau a me ka chiasm, me ka hoʻonui ʻia ʻana i ʻike ʻia. ʻAʻohe hōʻailona ʻē aʻe a i ʻole nā ​​hoʻonui ʻana i loaʻa i loko o ka parenchyma o ka lolo.


    I kēia manawa, ua hoʻomākaukau ka ʻohana no ka hoʻoili iwi iwi, e kali ana i kahi moe wale nō ma ka lumi hoʻoili. ʻO ka mea pōʻino, ua hōʻike nā hoʻokolohua maʻamau ma mua o ka hoʻoili ʻana i nā pilikia i hiki ʻole ai ke hoʻoili.

    2219

    Ma ʻAukake 30, ua hana ʻia kahi ʻō ʻana o ka iwi iwi, e hōʻike ana i ka MRD iwi iwi me nā lymphocytes T ʻōpiopio ʻē aʻe e helu ana no 61.1%. Ua hana pū ʻia kahi ʻō ʻana o ka lumbar me ka inikini intrathecal, e hōʻike ana i ka CSF MRD me 127 mau cell āpau, nona nā lymphocytes T ʻōpiopio ʻē aʻe he 35.4%, e hōʻike ana i ka hoʻi hou ʻana o ka leukemia.

    Ma ʻAukake 31, 2021, ua hōʻea ʻo Dawei a me kona ʻohana i ko mākou kikowaena CGT. Ua hōʻike ʻia nā hoʻokolohua koko komo: WBC 132.91 × 10 ^ 9 / L; ʻokoʻa koko peripheral (morphology): 76.0% blasts. Ua lawelawe ʻia ka chemotherapy induction no hoʻokahi papa.

    Ma hope o ka nānā hou ʻana i ka lāʻau lapaʻau mua a Dawei, ua maopopo he paʻakikī/hoʻi hou kāna T-ALL a ua komo nā pūnaewele tumor i loko o ka lolo, e hoʻopilikia ana i ke aʻalolo optic. Ua hoʻoholo ka hui lapaʻau ua hoʻokō ʻo Dawei i nā kūlana no ke kākau inoa ʻana i ka hoʻokolohua lapaʻau CD7 CAR-T.

    Ma Kepakemapa 18, ua hana ʻia kekahi hoʻokolohua ʻē aʻe: ua hōʻike ka ʻokoʻa koko peripheral (morphology) i 11.0% blasts. Ua hōʻiliʻili ʻia nā lymphocytes koko peripheral no ka moʻomeheu cell CD7 CAR-T i ka lā hoʻokahi, a ua holo mālie ke kaʻina hana. Ma hope o ka hōʻiliʻili ʻana, ua lawelawe ʻia ka chemotherapy e hoʻomākaukau no ka immunotherapy cell CD7 CAR-T.

    I ka wā o ka chemotherapy, ua ulu wikiwiki nā pūnaewele tumor. Ma ʻOkakopa 6, ua hōʻike ka ʻokoʻa koko peripheral (morphology) i 54.0% blasts, a ua hoʻoponopono ʻia ke ʻano chemotherapy e hōʻemi i ke kaumaha o ka tumor. Ma ʻOkakopa 8, ua hōʻike kahi loiloi morphology cell bone marrow i 30.50% blasts; Ua hōʻike ʻo MRD he 17.66% o nā cell he malignant immature T lymphocytes.

    Ma ʻOkakopa 9, ua hoʻokomo hou ʻia nā pūnaewele CD7 CAR-T. Ma hope o ka hoʻokomo hou ʻana, ua ʻike ka mea maʻi i ke kuni hou a me ka ʻeha o ka ʻāʻī. ʻOiai ua hoʻonui ʻia ka lāʻau anti-infection, ʻaʻole i kāohi maikaʻi ʻia ke kuni, ʻoiai ua emi mālie ka ʻeha o ka ʻāʻī.

    I ka lā 11 ma hope o ka hoʻokomo hou ʻana, ua piʻi aʻe ka nui o ke koko peripheral i 54%; i ka lā 12, ua hōʻike ʻia kahi hoʻāʻo koko e piʻi ana nā keʻokeʻo koko i 16 × 10 ^ 9 / L. I ka lā 14 ma hope o ka hoʻokomo hou ʻana, ua loaʻa i ka mea maʻi ka CRS koʻikoʻi, me ka hōʻino ʻana o ka myocardial, ka hana ʻino o ke akepaʻa a me nā puʻupaʻa, ka hypoxemia, ke kahe koko ʻana o ka ʻōpū haʻahaʻa, a me nā convulsions. ʻO nā lāʻau lapaʻau hōʻailona koʻikoʻi a me ke kākoʻo, me ka hoʻololi plasma, ua hoʻomaikaʻi mālie i ka hana o nā ʻōpū i hoʻopilikia ʻia, e hoʻopaʻa ana i nā hōʻailona koʻikoʻi o ka mea maʻi.

    Ma ʻOkakopa 27, ua loaʻa i ka mea maʻi ka ikaika o nā ʻiʻo 0-grade ma nā lālā haʻahaʻa ʻelua. Ma ʻOkakopa 29 (21 mau lā ma hope o ka hoʻokomo hou ʻana), ua lilo ka hoʻāʻo MRD iwi iwi i mea maikaʻi ʻole.

    I ke kūlana o ke kala piha ʻana, ua hoʻoikaika ʻo Dawei i ka hana o kona mau lālā haʻahaʻa me ke kōkua o nā kahu maʻi a me ka ʻohana, e hoʻihoʻi mālie ana i ka ikaika o nā ʻiʻo i 5 mau papa. Ma Nowemapa 22, ua hoʻoneʻe ʻia ʻo ia i ka ʻoihana hoʻoili e hoʻomākaukau no kahi hoʻoili cell kumu hematopoietic allogeneic.

    wehewehe2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write